申请人:Abbott Laboratories
公开号:US05691351A1
公开(公告)日:1997-11-25
Compounds having the structure ##STR1## where m is an integer of from one to nine; n is an integer of from one to four; W is selected from substituted or unsubstituted quinolyl, benzothiazolyl, or quinoxalyl, X is selected from C.sub.1-6 alkylene, C.sub.2-6 alkenylene and C.sub.2-6 alkynylene; Y is selected from halogen, C.sub.1-6 alkyl and C.sub.1-6, alkoxy; and Z is selected from --C(O)B; --C(R.sub.2).sup.2 --O--N.dbd.A--C(O)B; and --C(R.sup.2).dbd.N--O--A--C(O)B where A is C.sub.1-6 alkylene and B is --OH, --O--M.sup.+, --OD where D is a metabolically cleavable group, --OR.sup.6 where R.sup.6 is hydrogen or C.sub.1-6 alkyl, --NR.sup.6 R.sup.7 where R.sup.7 is hydrogen, C.sub.1-6 alkyl, hydroxy or C.sub.1-6 alkoxy, or where R.sup.6 and R.sup.7 taken together form a five to eight membered ring optionally containing one heteroatom selected from nitrogen, oxygen or sulfur, are inhibitors of leukotriene biosynthesis.
具有结构##STR1##的化合物,其中m是1至9的整数;n是1至4的整数;W选自取代或未取代的喹啉基,苯并噻唑基或喹噁啉基;X选自C.sub.1-6烷基,C.sub.2-6烯基和C.sub.2-6炔基;Y选自卤素,C.sub.1-6烷基和C.sub.1-6烷氧基;Z选自--C(O)B;--C(R.sub.2).sup.2 --O--N.dbd.A--C(O)B;和--C(R.sup.2).dbd.N--O--A--C(O)B,其中A是C.sub.1-6烷基,B是--OH,--O--M.sup. +,--OD,其中D是代谢可降解的基团,--OR.sup.6,其中R.sup.6是氢或C.sub.1-6烷基,--NR.sup.6 R.sup.7,其中R.sup.7是氢,C.sub.1-6烷基,羟基或C.sub.1-6烷氧基,或者其中R.sup.6和R.sup.7一起形成一个五至八元环,可选地含有一个来自氮,氧或硫的杂原子,是白三烯生物合成的抑制剂。